Pfizer Inc. (LON: 0Q1N)

Pfizer Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 28, 2024	Dec 30, 2023	Dec 30, 2022	Dec 30, 2021	Dec 30, 2020	Dec 30, 2019
Revenue	59,375	58,496	100,330	81,288	41,651	40,905
Revenue Growth (YoY)	-14.29%	-41.70%	23.43%	95.16%	1.82%	0.20%
Cost of Revenue	17,944	23,989	34,097	30,686	8,385	7,847
Gross Profit	41,431	34,507	66,233	50,602	33,266	33,058
Selling, General & Admin	14,148	13,836	12,200	9,562	11,418	12,766
Research & Development	10,595	10,679	11,428	10,360	8,709	7,721
Operating Expenses	29,937	29,248	27,237	23,622	23,475	24,916
Operating Income	11,494	5,259	38,996	26,980	9,791	8,142
Interest Expense	-3,040	-2,209	-1,238	-1,291	-1,449	-1,573
Interest & Investment Income	1,429	2,100	565	202	351	445
Earnings From Equity Investments	253	505	436	471	298	17
Currency Exchange Gain (Loss)	164	164	-1,153	-	-	-
Other Non Operating Income (Expenses)	536	1,275	2,619	1,904	1,639	1,365
EBT Excluding Unusual Items	10,836	7,094	40,225	28,266	10,630	8,396
Merger & Restructuring Charges	-5,869	-3,999	-2,225	-1,452	-895	-1,095
Gain (Loss) on Sale of Investments	2,578	1,590	-1,273	1,344	557	8,561
Gain (Loss) on Sale of Assets	222	222	-	-	-237	32
Asset Writedown	-2,997	-3,024	-421	-86	-1,691	-2,792
Legal Settlements	-650	-474	-230	-182	-28	-292
Other Unusual Items	-12	-157	-394	-111	-616	-1,490
Pretax Income	3,904	1,058	34,729	24,310	7,036	11,320
Income Tax Expense	-402	-1,115	3,328	1,852	370	583
Earnings From Continuing Operations	4,306	2,173	31,401	22,458	6,666	10,737
Earnings From Discontinued Operations	-22	-15	6	-434	2,529	5,318
Net Income to Company	4,284	2,158	31,407	22,024	9,195	16,055
Minority Interest in Earnings	-32	-39	-35	-45	-36	-29
Net Income	4,252	2,119	31,372	21,979	9,159	16,026
Preferred Dividends & Other Adjustments	-	-	-	-	-	1
Net Income to Common	4,252	2,119	31,372	21,979	9,159	16,025
Net Income Growth	-59.44%	-93.25%	42.74%	139.97%	-42.85%	43.69%
Shares Outstanding (Basic)	5,659	5,643	5,608	5,601	5,555	5,569
Shares Outstanding (Diluted)	5,698	5,709	5,733	5,708	5,632	5,675
Shares Change (YoY)	-0.42%	-0.42%	0.44%	1.35%	-0.76%	-5.05%
EPS (Basic)	0.75	0.38	5.59	3.92	1.65	2.88
EPS (Diluted)	0.74	0.37	5.47	3.85	1.63	2.82
EPS Growth	-59.45%	-93.29%	41.96%	136.58%	-42.31%	51.34%
Free Cash Flow	8,227	4,793	26,031	29,869	12,177	10,542
Free Cash Flow Per Share	1.44	0.84	4.54	5.23	2.16	1.86
Dividend Per Share	1.670	1.640	1.600	1.560	1.520	1.440
Dividend Growth	2.45%	2.50%	2.56%	2.63%	5.56%	5.88%
Gross Margin	69.78%	58.99%	66.02%	62.25%	79.87%	80.82%
Operating Margin	19.36%	8.99%	38.87%	33.19%	23.51%	19.90%
Profit Margin	7.16%	3.62%	31.27%	27.04%	21.99%	39.18%
Free Cash Flow Margin	13.86%	8.19%	25.95%	36.74%	29.24%	25.77%
EBITDA	18,366	11,517	44,024	32,084	14,455	13,857
EBITDA Margin	30.93%	19.69%	43.88%	39.47%	34.70%	33.88%
D&A For EBITDA	6,872	6,258	5,028	5,104	4,664	5,715
EBIT	11,494	5,259	38,996	26,980	9,791	8,142
EBIT Margin	19.36%	8.99%	38.87%	33.19%	23.51%	19.90%
Effective Tax Rate	-	-	9.58%	7.62%	5.26%	5.15%
Revenue as Reported	59,376	58,496	100,330	81,288	-	-
Advertising Expenses	-	3,700	2,800	2,000	1,800	2,300

Source: S&P Capital IQ. Standard template. Financial Sources.